Overview
Brecht Guillemyn practices in Gent, Belgium. Guillemyn is rated as an Experienced expert by MediFind in the treatment of Chondrodystrophy. Their top areas of expertise are Vascular Ehlers-Danlos Syndrome (VEDS), Ehlers-Danlos Syndrome (EDS), Osteogenesis Imperfecta, and Cutis Laxa.
Their clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chondrodystrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Brachydactyly Mononen TypeGuillemyn isAdvanced. Learn about Brachydactyly Mononen Type.
- Cutis LaxaGuillemyn isAdvanced. Learn about Cutis Laxa.
- Ehlers-Danlos Syndrome (EDS)Guillemyn isAdvanced. Learn about Ehlers-Danlos Syndrome (EDS).
- Osteogenesis ImperfectaGuillemyn isAdvanced. Learn about Osteogenesis Imperfecta.
- Vascular Ehlers-Danlos Syndrome (VEDS)
- Experienced
- Autosomal Recessive Cutis Laxa Type 1Guillemyn isExperienced. Learn about Autosomal Recessive Cutis Laxa Type 1.
- Batten DiseaseGuillemyn isExperienced. Learn about Batten Disease.
- ChondrodystrophyGuillemyn isExperienced. Learn about Chondrodystrophy.
- CLN1 DiseaseGuillemyn isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseGuillemyn isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseGuillemyn isExperienced. Learn about CLN3 Disease.